OPKO HEALTH, INC. 8-K

What Happened OPKO Health, Inc. (OPK) filed an 8‑K on March 19, 2026 announcing that its Board appointed Subbarao V. Uppaluri, Ph.D., as a director effective March 18, 2026. Dr. Uppaluri will serve until the Company’s 2026 Annual Meeting of Stockholders (or until his successor is elected) and is expected to join the Board’s Compensation Committee. The appointment filled the vacancy created by the passing of Dr. Richard Krasno. The Board has determined Dr. Uppaluri is independent under SEC and Nasdaq rules.

Key Details

• Appointment effective March 18, 2026; will serve until the 2026 Annual Meeting.
• Expected membership: Compensation Committee.
• Background: OPKO CFO from May 2007–July 2012 and consultant to OPKO until Feb 2014; previously VP, Strategic Planning & Treasurer of IVAX (1997–Dec 2006).
• No related-party transactions since the start of OPKO’s last fiscal year that require Item 404 disclosure; will receive standard non‑employee director compensation and has OPKO’s standard director indemnification agreement.

Why It Matters This is a governance change that affects OPKO’s board composition and oversight: an experienced former OPKO CFO joins as an independent director and will participate in compensation oversight as a Compensation Committee member. For investors, the filing confirms there are no disclosed conflicts of interest tied to his appointment and that his role is initially to fill a vacancy until the next shareholder vote.